We further demonstrated that the augmented PAGE4 could promote cell survival by activating the phosphorylation of ERK1/2 and decrease cell apoptosis by inhibiting the phosphorylation of JNK1/2 under the presence of OS, which could contribute to the development of BPH. The gene discussed is MAPK3; the disease is benign prostatic hyperplasia.